Westfield Capital Management Co. LP Boosts Stake in Option Care Health, Inc. (NASDAQ:OPCH)

Westfield Capital Management Co. LP raised its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 10.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,492,152 shares of the company’s stock after buying an additional 599,589 shares during the quarter. Option Care Health comprises 0.9% of Westfield Capital Management Co. LP’s portfolio, making the stock its 18th biggest holding. Westfield Capital Management Co. LP owned approximately 3.81% of Option Care Health worth $203,204,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in OPCH. UMB Bank n.a. grew its holdings in shares of Option Care Health by 937.5% in the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after purchasing an additional 750 shares in the last quarter. GAMMA Investing LLC raised its position in Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after purchasing an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. lifted its stake in shares of Option Care Health by 3,362.8% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after purchasing an additional 1,446 shares during the last quarter. Blue Trust Inc. boosted its holdings in shares of Option Care Health by 14.8% in the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after purchasing an additional 377 shares during the period. Finally, International Assets Investment Management LLC increased its position in shares of Option Care Health by 3,029.7% during the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after purchasing an additional 2,757 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Insider Buying and Selling

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of Option Care Health stock in a transaction that occurred on Friday, November 8th. The stock was bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the purchase, the director now directly owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.64% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on OPCH. Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. JMP Securities lifted their price target on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research note on Monday, September 30th. Truist Financial cut their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. The Goldman Sachs Group lowered Option Care Health from a “buy” rating to a “neutral” rating and dropped their target price for the company from $38.00 to $27.00 in a research report on Monday, November 4th. Finally, Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and reduced their price target for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, Option Care Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $30.83.

Option Care Health Stock Performance

Option Care Health stock opened at $23.13 on Friday. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $34.63. The company has a market capitalization of $3.94 billion, a PE ratio of 19.44, a P/E/G ratio of 2.33 and a beta of 1.32. The company has a 50 day moving average price of $27.62 and a 200-day moving average price of $29.10. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.